AIM - Latest News

AIM ImmunoTech Inc. (AIM), operates in Healthcare / Biotechnology, trades on AMEX.

Market capitalization stands near $878,113. Beta to the broader market is 1.20.

The article list below shows the most recent AIM headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent AIM Headlines

CelLBxHealth builds £3.5m weighted pipeline as revenue growth target held

proactiveinvestors.co.uk - Jul 15, 2026

CelLBxHealth PLC (AIM:CLBX, FRA:DWV), the AIM-listed cancer diagnostics company, said its commercially weighted pipeline had built to £3. 5 million, s

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

globenewswire.com - Jul 7, 2026

CEO Thomas Equels discusses recent clinical progress, upcoming milestones and the Company's commitment to advancing Ampligen® for patients with pancre

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

globenewswire.com - Jul 7, 2026

Access it here OCALA, Fla. , July 07, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc.

Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion

proactiveinvestors.co.uk - Jul 7, 2026

Coiled Therapeutics (AIM:COIL, OTCQB:COTXF), a clinical-stage oncology company developing medicines for hard-to-treat cancers, has created a new oral

Phoenix Copper shares drop on discount equity raise

proactiveinvestors.co.uk - Jul 6, 2026

Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF, FRA:5HR) said it plans to raise around £2. 3 million through a placing and subscription at a steep discount,

How News Affects AIM Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AIM's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked AIM news questions

What is the latest AIM news headline?

The most recent AIM headline (Jul 15, 2026) is "CelLBxHealth builds £3.5m weighted pipeline as revenue growth target held". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the AIM news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What AIM news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual AIM options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.